Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation-百迪生物科技

首页 > 文献支持 > Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation

2025-03-15·文献支持

加入收藏去分享

发布日期： 2025-03-15

来源：

作者： Chunyan Mu, Kaiquan Shao, Mingyu Su, Yurong Guo, Yuxiang Qiu, Ruiao Sun, Sihan Sun, Yaoyu Sun, Chenkai Liu, Wei Wang, Xiaoling Qin & Chuanxi Tang

加入收藏去分享

来源网址：https://www.nature.com/articles/s41531-025-00902-7

期刊：npj Parkinson's Disease丨丨引用百迪产品：H803000 6孔细胞培养板（PS，TC处理，灭菌，无酶）

IF：6.7

上一篇

日期：2025-03-15

Gel-to-Coacervate Transition in Peptide/HA Complexes for MMP-9-Activated Penetration into Tumor Spheroids

下一篇

日期：2025-03-03

Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus

400-601-2023

service@biocode.cn

浙江省杭州市余杭区良渚生命科技小镇5号楼4楼（公司总部）

百迪科技所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务 CopyRight © 2023 浙江百迪生物科技有限公司 All Rights Reserved. 浙ICP备2022012557号-2

网站技术支持：宽尔科技